The Delpharm-operated site will help provide up to 51 million additional doses of Comirnaty in 2021, the EMA said.The regulator also said it had approved a new manufacturing line at BioNTech's site at Marburg in Germany, which would help boost capacity for the vaccine's active substance by about 410 million doses this year.
Europe's medicines regulator has approved additional manufacturing sites for mRNA-based coronavirus vaccines developed by Pfizer-BioNTech and Moderna to help boost production amid a resurgence in infections.
The European Medicines Agency (EMA) said https://www.ema.europa.eu/en/news/increase-vaccine-manufacturing-capacity-covid-19-vaccines-biontech-pfizer-moderna on Tuesday its human medicines committee had approved a site at Saint Remy sur Avre in France for making the Pfizer-BioNTech vaccine, Comirnaty.
Limited time offer:
Just RM5 per month.
